A slim majority of FDA advisory panelists rejected that the benefits of a radiofrequency renal denervation system outweigh the risks for use in adults with uncontrolled hypertension despite use of antihypertensive medications.\n\n https://yamcode.com/holland-says-wants-update-1232 https://yamcode.com/raw/holland-says-wants-update-1232 https://yamcode.com/china-president-says-wants-update-1416 https://yamcode.com/raw/china-president-says-wants-update-1416